Latest Earnings Results: Q2 '26
Estimated EPS
$0.48
Reported EPS
$0.56
Surprise
+16.55%
Estimated Rev
$417.54M
Reported Rev
$418.76M
Surprise
+0.29%
$IART Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.06 up 100.95% YoY • Reported revenue of $418.76M up 0.76% YoY • Integra LifeSciences updates its 2026 reported revenue guidance range to $1.654 billion to $1.695 billion, while reaffirming full-year organic revenue growth of 0.8% to 3.3% and adjusted EPS of $2.40 to $2.50.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $0.56 | -- | -- | N/A |
Q2 '26 | $0.48 | $0.56 | 16.55% | BEAT |
Q1 '26 | $0.40 | $0.54 | 33.35% | BEAT |
Q4 '25 | $0.80 | $0.83 | 3.73% | BEAT |
Q3 '25 | $0.43 | $0.54 | 24.31% | BEAT |